Fig. 12

FIG 12. We perform ICGA-guided PDTin some patients in stages I and II, with the smallest possible spot covering the neovascularization, associated to anti-VEGF drugs. This technique would use smaller spots, thereby contributing to lessen the risk of long-term atrophy in these patients. The figure shows the outcome three years after the treatment.